Header cover image

Chinese (SSE) Life Sciences Industry Analysis

UpdatedJan 26, 2022
DataAggregated Company Financials
  • 7D-3.4%
  • 3M-23.3%
  • 1Y-19.9%
  • YTD-3.0%

Over the last 7 days, the Life Sciences industry has dropped 4.5%, driven by a pullback from WuXi AppTec of 2.1%. However, the industry is down 25% over the past year.

Industry Valuation and Performance

Has the Chinese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 26 Jan 2022CN„670.6bCN„57.5bCN„12.3b71.4x
Fri, 24 Dec 2021CN„709.7bCN„56.9bCN„12.1b81.1x
Sun, 21 Nov 2021CN„831.5bCN„56.9bCN„12.1b91.7x
Tue, 19 Oct 2021CN„906.8bCN„53.4bCN„11.5b108.6x
Thu, 16 Sep 2021CN„958.2bCN„55.1bCN„12.7b98.6x
Sat, 14 Aug 2021CN„908.4bCN„53.4bCN„11.5b104.2x
Wed, 09 Jun 2021CN„856.8bCN„46.5bCN„10.6b93.7x
Tue, 02 Mar 2021CN„674.5bCN„39.5bCN„7.8b76.7x
Fri, 04 Dec 2020CN„508.3bCN„36.6bCN„6.7b79.5x
Mon, 07 Sep 2020CN„542.7bCN„34.2bCN„6.3b97.7x
Sun, 31 May 2020CN„387.2bCN„32.6bCN„4.5b90.3x
Wed, 04 Mar 2020CN„328.6bCN„32.0bCN„4.4b81.2x
Sat, 07 Dec 2019CN„266.5bCN„30.0bCN„4.1b68.2x
Tue, 10 Sep 2019CN„247.0bCN„27.6bCN„3.8b72.6x
Mon, 03 Jun 2019CN„180.2bCN„26.0bCN„3.9b63.8x
Thu, 07 Mar 2019CN„183.7bCN„24.6bCN„3.8b59.6x
PE Ratio


Total Market Cap: CN„139.7bTotal Earnings: CN„3.8bTotal Revenue: CN„24.6b0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 79.5x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Life Sciences industry have grown 49% per year over the last three years, and revenues for these companies have grown 33% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Chinese Life Sciences industry?

Clinical Research and Equipment-3.43%

Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry, which is trading close to its 3-year average PE ratio of 79.5x. However analysts are expecting annual earnings growth of 26%, which is lower than the prior year's growth of 61% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 26% over the next 5 years. However this is lower than its past earnings growth rate of 61% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603127 Joinn Laboratories (China)LtdCN„99.541.0%
Simply Wall Stℱ
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News